

Printed Electronics World
Jun 21, 2016

ITO alternatives: light at the end of the tunnel
The TCF industry has recently experienced sluggish growth. The industry has transitioned from being supply-limited to being commoditized and demand-limited with supply currently outstripping demand. This is a commonplace characteristic of supply industry into consumer electronic devices: there is often a scramble for supplies as demand rapidly takes off but the industry soon over-invests, the capacity overshoots demand, and competition renders the component a commodity.
Printed Electronics World
Jun 13, 2016

Microcontrollers and single-board computers 2016-2026
The unique new IDTechEx Research report, Microcontrollers and Single-board Computers 2016-2026, is the first to reveal the big picture developing from the close relationship between these devices. It provides newly researched forecasts leading to figures such as $300bn in 2026 for SBC alone.
Printed Electronics World
Jun 9, 2016

Better adhesives allowing more accurate, compact medical equipment
Advancements in electronics technology are enabling medical electronic equipment designed for faster diagnosis, improved patient quality of life, and new drug-based therapies.
Printed Electronics World
Jun 21, 2016

ITO alternatives: light at the end of the tunnel
The TCF industry has recently experienced sluggish growth. The industry has transitioned from being supply-limited to being commoditized and demand-limited with supply currently outstripping demand. This is a commonplace characteristic of supply industry into consumer electronic devices: there is often a scramble for supplies as demand rapidly takes off but the industry soon over-invests, the capacity overshoots demand, and competition renders the component a commodity.
Printed Electronics World
Jun 9, 2016

Better adhesives allowing more accurate, compact medical equipment
Advancements in electronics technology are enabling medical electronic equipment designed for faster diagnosis, improved patient quality of life, and new drug-based therapies.